News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
680,588 Results
Type
Article (39067)
Company Profile (247)
Press Release (641274)
Section
Business (203762)
Career Advice (1977)
Deals (35385)
Drug Delivery (78)
Drug Development (80763)
Employer Resources (167)
FDA (16084)
Job Trends (14795)
News (344235)
Policy (32468)
Tag
Academia (2540)
Africa (711)
Alliances (49030)
Alzheimer's disease (1148)
Approvals (16007)
Arizona (175)
Artificial intelligence (69)
Asia (36957)
Australia (6010)
Bankruptcy (350)
Best Places to Work (11289)
Biosimilars (63)
Biotechnology (176)
C2C Services and Suppliers (79300)
California (1869)
Canada (930)
Cancer (487)
Career advice (1647)
Cell therapy (119)
China (150)
Clinical research (63317)
Collaboration (139)
Colorado (75)
Compensation (81)
Connecticut (73)
COVID-19 (2487)
Cystic fibrosis (73)
Data (312)
Diabetes (81)
Diagnostics (5977)
Drug pricing (64)
Earnings (83735)
Employer resources (142)
Europe (78913)
Events (107993)
Executive appointments (150)
FDA (16311)
Florida (263)
Funding (148)
Gene therapy (91)
GLP-1 (510)
Government (4301)
Healthcare (18645)
Hotbed/Location (481772)
Illinois (254)
Indiana (146)
Infectious disease (2514)
Inflammatory bowel disease (91)
Interviews (306)
IPO (16213)
Job creations (3625)
Job search strategy (1412)
Kansas (94)
Layoffs (393)
Legal (7847)
Lung cancer (110)
Manufacturing (86)
Maryland (395)
Massachusetts (1516)
Medical device (13101)
Medtech (13106)
Mergers & acquisitions (19038)
Metabolic disorders (247)
Michigan (124)
Minnesota (215)
Neuroscience (1292)
New Jersey (577)
New York (591)
NextGen Class of 2024 (6482)
Non-profit (4464)
North Carolina (587)
Northern California (823)
Obesity (146)
Ohio (104)
Opinion (172)
Patents (71)
Pennsylvania (579)
People (55914)
Pharmaceutical (60)
Phase I (19620)
Phase II (27884)
Phase III (20826)
Pipeline (112)
Postmarket research (2555)
Preclinical (8345)
Press Release (64)
Rare diseases (129)
Real estate (5886)
Recruiting (63)
Regulatory (21231)
Research institute (2309)
Resumes & cover letters (346)
South America (1086)
Southern California (758)
Startups (3567)
Texas (238)
United States (8518)
Vaccines (472)
Washington State (254)
Weight loss (127)
Date
Today (112)
Last 7 days (666)
Last 30 days (2413)
Last 365 days (37211)
2024 (26142)
2023 (40120)
2022 (51217)
2021 (55747)
2020 (54136)
2019 (46621)
2018 (35064)
2017 (32181)
2016 (31566)
2015 (37631)
2014 (31423)
2013 (26468)
2012 (28695)
2011 (29372)
2010 (27459)
680,588 Results for "lemaitre vascular inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
LeMaitre to Present at the 2024 Jefferies Global Healthcare Conference
LeMaitre Vascular, Inc. announced that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00 AM ET at the Marriott Marquis in New York City.
May 21, 2024
·
1 min read
Genetown
LeMaitre to Participate at Upcoming Investor Conferences in March 2024
LeMaitre Vascular, Inc. announced that management will be participating in four upcoming investor conferences in March.
March 1, 2024
·
1 min read
Business
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close.
April 19, 2024
·
1 min read
Business
LeMaitre Q1 2024 Financial Results
LeMaitre, a provider of vascular devices, implants and services, reported Q1 2024 results, announced a $0.16/share quarterly dividend and provided guidance.
May 2, 2024
·
12 min read
Genetown
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 11:30 AM ET.
March 26, 2024
·
1 min read
Business
LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024, after the market close.
February 13, 2024
·
1 min read
Business
LeMaitre Q4 2023 Financial Results
LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2023 results, announced a $0.16/share quarterly dividend and provided guidance.
February 27, 2024
·
12 min read
Business
LeMaitre to Participate at Upcoming Investor Conferences in September
August 27, 2024
·
1 min read
Genetown
LeMaitre to Present at the 26th Annual Needham Growth Conference
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 26th Annual Needham Growth Conference on Friday, January 19, 2024, at 11:00 AM ET.
January 11, 2024
·
1 min read
Genetown
LeMaitre to Participate at Upcoming Investor Conferences in November
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
November 3, 2023
·
1 min read
1 of 68,059
Next
